Speaker illustration

Doctor Sebastian Ludwig

University Heart and Vascular Center Hamburg, Hamburg (Germany)

Member of:

European Society of Cardiology

Interventional cardiologist in training at University Heart and Vascular Centre Hamburg, Germany

Outcomes of patients with severe mitral regurgitation treated with transcatheter mitral valve implantation or medical therapy

Event: EuroEcho 2021

Topic: Imaging of Valvular Heart Disease

Session: e-posters session - Cross-Modality and Multi-Modality Imaging Topics

Thumbnail

Repair or replace? TEER versus TMVI for secondary MR

Event: ESC Congress 2021 - The Digital Experience

Topic: Mitral Valve Intervention

Session: Registries on Valve

Thumbnail

Risk prediction in patients with classical Low-flow, low-gradient aortic stenosis undergoing TAVI

Event: ESC Congress 2021 - The Digital Experience

Topic: Aortic Valve Intervention

Session: Highlights from the Young in Intervention

Thumbnail

The adverse impact of HFpEF in patients with aortic stenosis: Evaluation of the H2FPEF score for risk assessment among patients with preserved ejection fraction undergoing TAVI

Event: ESC Congress 2020

Topic: Aortic Valve Intervention

Session: Optimizing Risk Stratification and Technical Aspects of TAVI Procedures

Thumbnail

Prognostic value of high-sensitivity troponin I measured by two assays in patients presenting with suspected myocardial infarction

Event: ESC Congress 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Coronary artery disease - Epidemiology, prognosis, outcome

Thumbnail

High H2FPEF score is an independent predictor of adverse outcome in patients with severe aortic stenosis and preserved ejection fraction undergoing TAVR

Event: ESC Congress 2019

Topic: Aortic Valve Intervention

Session: TAVR outcomes: the future is here

Thumbnail

ESC 365 is supported by

logo Novo Nordisk